Cargando…

Umbilical cord blood: A promising source for allogeneic CAR-T cells

Chimeric antigen receptor T (CAR-T) cell therapy is an effective treatment for relapsed and refractory acute lymphoblastic leukemia (R/R ALL). However, autologous CAR-T cells derived from patients with B-ALL often show poor amplification ability, exhaustion, and anergy. To overcome these limitations...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Dian-Dian, Hong, Wei-Cong, Qiu, Kun-Yin, Li, Xin-Yu, Liu, Yong, Zhu, Li-Wen, Lai, Wei-Xin, Chen, Han-, Yang, Hua-Qing, Xu, Lu-Hong, Fang, Jian-Pei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373021/
https://www.ncbi.nlm.nih.gov/pubmed/35965561
http://dx.doi.org/10.3389/fonc.2022.944248